Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Spine Wave's vertebral devices:

This article was originally published in Clinica

Executive Summary

Spine Wave has received US FDA clearance to market two complementing products for treating vertebral compression fractures - the StaXx FX structural kyphoplasty system and the CapSure PS pedicle screw. The minimally invasive StaXx FX system will allow Spine Wave to enter "a large, rapidly growing market" with what it claims is "a highly differentiated technology". The product features PEEK wafers that are stacked in situ to simultaneously distract and support the fractured vertebral body, providing pain relief and a controlled vertical fracture reduction. The CapSure product, the company adds, has a unique design that allows it to maintain maximum polyaxial angulation even when the screw is fully seated into the pedicle. The Shelton, Connecticut, firm is initiating a controlled release of both products during the second quarter of 2007, and anticipates a broader market launch by the end of this year.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT048166

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel